Last 47 quarters of trend data · Healthcare · Cannabis
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -0.00 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 16.68 | — | 46.41 | — | — | — | 1.48 | 4.39 | 3.35 | 2.70 | 3.34 | 2.24 | 196.41 | 362.70 | 421.24 | 329.78 | 437.26 | 1028.89 | 1018.04 | 466.41 | 863.42 |
| — | — | +3029.5% | — | — | — | -55.6% | +95.8% | -98.3% | -99.3% | -99.2% | -99.3% | -55.1% | -64.7% | -58.6% | -29.3% | -49.4% | -23.6% | -45.7% | -78.8% | -86.9% | |
| P/B Ratio | — | — | — | — | 0.76 | 0.82 | — | — | — | — | — | — | — | 1898.45 | 1292.05 | 678.02 | 852.51 | 1616.01 | 1102.06 | 643.79 | 981.21 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | +17.5% | +17.2% | +5.3% | -13.1% | +18.7% | -88.4% | — | -66.6% | |
| P/FCF | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 23.1% | — | -11249.9% | -13.0% | — | — | -6.9% | -58.6% | 29.6% | 23.4% | 10.6% | 27.3% | 25.2% | -4.4% | 30.3% | 68.1% | 23.6% | 15.0% | 21.2% | 11.1% | 29.0% |
| — | — | -161860.0% | +77.9% | — | — | -165.4% | -315.0% | +17.6% | +631.7% | -64.9% | -59.9% | +6.7% | -129.4% | +42.8% | +514.5% | -18.5% | -45.6% | -24.1% | +413.9% | -33.3% | |
| Operating Margin | -19415.6% | — | -23888.4% | 267.4% | — | — | -463.8% | -1098.4% | -271.9% | -352.6% | -211.0% | -122.3% | -84.0% | -81.3% | -59.3% | -99.6% | -104.9% | -129.6% | -144.8% | -200.9% | -427.0% |
| — | — | -5051.0% | +124.3% | — | — | -119.8% | -798.4% | -223.5% | -333.9% | -255.5% | -22.8% | +19.9% | +37.3% | +59.0% | +50.4% | +75.4% | +36.5% | +20.3% | +80.9% | -87.9% | |
| Net Margin | -34537.0% | — | -50579.3% | 877.7% | — | — | -832.9% | -1542.9% | -480.7% | -508.9% | -303.2% | -223.0% | -110.2% | -108.0% | -64.0% | -100.0% | -106.3% | -130.6% | -152.7% | -199.1% | -431.2% |
| — | — | -5972.5% | +156.9% | — | — | -174.7% | -592.0% | -336.1% | -371.2% | -373.4% | -122.9% | -3.7% | +17.3% | +58.0% | +49.8% | +75.3% | +34.6% | +16.9% | +89.0% | -108.9% |
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | — | — | — | — | -127.6% | -97.4% | — | — | — | — | — | — | -342.4% | -97.0% | -44.1% | -49.6% | -48.3% | -45.2% | -51.3% | -64.8% | -106.2% |
| — | — | — | — | — | — | — | — | — | — | — | — | -609.3% | -114.5% | +14.0% | +23.4% | +54.6% | +48.6% | +89.6% | +87.2% | -321.1% | |
| ROA | -1354.9% | -222.6% | -246.2% | -27.3% | -44.2% | -68.6% | -138.6% | -162.5% | -57.5% | -64.1% | -50.6% | -56.7% | -46.5% | -39.4% | -22.8% | -28.8% | -31.5% | -31.3% | -32.4% | -34.0% | -57.6% |
| — | -224.3% | -77.6% | +83.2% | +23.1% | -7.1% | -173.8% | -186.6% | -23.6% | -62.7% | -121.6% | -96.8% | -47.5% | -25.7% | +29.5% | +15.3% | +45.3% | +17.5% | +23.6% | +83.2% | -231.5% | |
| ROIC | — | — | — | -36.5% | -55.3% | -46.0% | — | — | -545.6% | -258.1% | -102.9% | -50.2% | -43.8% | -34.3% | -26.8% | -37.4% | -39.0% | -45.4% | -45.4% | -57.2% | -137.9% |
| — | — | — | — | +89.9% | +82.2% | — | — | -1147.1% | -652.0% | -284.1% | -34.2% | -12.2% | +24.4% | +40.9% | +34.5% | +71.7% | +45.8% | +33.7% | +61.6% | -598.4% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | — | — | — | — | 0.95 | 0.49 | — | — | — | — | — | — | — | 1.34 | 0.61 | 0.47 | 0.25 | 0.22 | 0.24 | 0.52 | 0.50 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | +498.0% | +157.6% | -10.6% | -50.9% | -44.9% | -91.0% | — | +400.8% | |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Current Ratio | 0.04 | 0.05 | 0.04 | 0.04 | 0.13 | 0.12 | 0.08 | 0.10 | 0.17 | 0.15 | 0.17 | 0.27 | 0.46 | 0.81 | 1.82 | 2.15 | 1.68 | 2.12 | 2.37 | 1.23 | 2.03 |
| — | -55.2% | -49.7% | -60.5% | -26.3% | -20.9% | -50.2% | -63.5% | -62.8% | -81.3% | -90.8% | -87.4% | -72.6% | -62.1% | -23.5% | +74.4% | -17.3% | -15.7% | +264.0% | +197.0% | +155.5% | |
| Quick Ratio | 0.04 | 0.05 | 0.04 | 0.04 | 0.07 | 0.06 | 0.04 | 0.05 | 0.10 | 0.07 | 0.08 | 0.12 | 0.20 | 0.40 | 1.17 | 1.40 | 0.99 | 1.53 | 2.00 | 0.95 | 1.76 |
| — | -9.9% | -5.7% | -29.5% | -25.3% | -23.8% | -49.1% | -55.4% | -51.9% | -81.8% | -93.2% | -91.6% | -79.9% | -73.7% | -41.2% | +47.5% | -43.9% | -33.8% | +307.0% | +254.6% | +177.4% | |
| Interest Coverage | -4.57 | -8.21 | -1.12 | -0.37 | -27.60 | -5.53 | -1.26 | -1.35 | -1.74 | -2.26 | -2.29 | -1.28 | -3.21 | -3.32 | -7.99 | -183.69 | -77.21 | -79.30 | -66.19 | -60.06 | -120.54 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 47 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying EDVA stock.
Endovia Health Sciences, Inc.'s current P/E is -0.0x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Endovia Health Sciences, Inc.'s current operating margin is -19415.6%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Endovia Health Sciences, Inc.'s business trajectory between earnings reports.